Advertisement
Product › Details
cell therapy
Next higher product group | BIOTECH | |
Record changed: 2024-07-20 |
Advertisement
More documents for cell therapy
- [1] Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna....
- [2] Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen....
- [3] Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg....
- [4] Lift BioSciences Ltd.. (9/24/24). "Press Release: Lift BioSciences Raises £10m in First Close of Series A to Advance First-in-Class Allogeneic Innate Cell Therapy". Milan....
- [5] Miltenyi Biotec B.V. & Co. KG. (9/10/24). "Press Release: Miltenyi Biotec Manufactures Lentiviral Vector for Adaptimmune’s FDA-approved TCR T-cell therapy Tecelra (afamitresgeme autoleucel)". Bergisch Gladbach....
- [6] Medigene AG. (9/5/24). "Press Release: Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications". Planegg....
- [7] Adaptimmune Therapeutics plc. (8/1/24). "Press Release: Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor". Philadeliphia, PA & Oxford....
- [8] Immatics N.V.. (7/31/24). "Press Release: Immatics Appoints Alise Reicin to Board of Directors". Houston, TX & Tübingen....
- [9] Pan Cancer T B.V.. (7/11/24). "Press Release: Pan Cancer T Secures EUR 4.25 Million in Seed Extension Round to Advance Next-generation T Cell Therapies". Rotterdam....
- [10] Berlin Institute of Health. (6/12/24). "Press Release: New Perspectives for Patients. National Strategy for Gene and Cell Therapies Presented to the BMBF"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top